NCT03890328

Brief Summary

Radiofrequency (RF) can be used to treat splenic trauma because of its excellent coagulation hemostasis. This study aimed to compare the efficacy of RF-assisted spleen-preserving surgery with that of conventional splenorrhaphy/splenectomy in the treatment of blunt splenic injury. A total of 122 patients with splenic trauma admitted to two tertiary referral centers from June 2011 to June 2014 were included in this prospective cohort study. The 67 patients at one center were treated by radiofrequency-assisted spleen-preserving therapy (RF group), and the 55 patients admitted at the other center underwent conventional treatment (CT group). Demographics and clinical characteristics of the two groups were comparable. Compared to traditional splenorrhaphy and splenectomy, RF-assisted splenic hemostasis and salvage was safe, effective and easy to use in the treatment of splenic injuries. In particular for high-grade splenic injuries, these techniques preserved sufficient splenic tissue without any increase in patients with surgical risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
4.8 years until next milestone

First Submitted

Initial submission to the registry

March 20, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 26, 2019

Completed
Last Updated

March 26, 2019

Status Verified

March 1, 2009

Enrollment Period

5.3 years

First QC Date

March 20, 2019

Last Update Submit

March 24, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mean operative time,

    Mean operative time of the RF group was compared with that of CT group.

    intraoperative

  • intraoperative bleeding

    Intraoperative bleeding of the RF group was compared with that of CT group.

    intraoperative

Study Arms (2)

RF group

EXPERIMENTAL

radiofrequency-assisted spleen-preserving therapy group.

Procedure: radiofrequency ablation

CT group

NO INTERVENTION

Conventional Treatment of Blunt Splenic Injury group.

Interventions

apply RF therapy to the treatment of splenic trauma

RF group

Eligibility Criteria

AgeUp to 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • age below 70
  • blunt abdominal injury combined with indication of post-traumatic splenectomy according to the guidelines provided by the Society for Surgery of the Alimentary Tract in 2005
  • patients transferred directly to the trauma center after injury who had not been treated by any specific spleen-directed therapy in the transferring hospital
  • AAST grade II splenic injury with hemodynamic instability or progressive bleeding requiring active intervention
  • AAST grade Ⅲ-Ⅳsplenic injury, or splenic laceration involving less than 50% of the splenic parenchyma

You may not qualify if:

  • penetrating abdominal injury
  • concomitant organ injury with an abbreviated injury scale (AIS) greater than 4 that threatened the life of the patient
  • excessive vascular injury to the splenic pedicle or substantial devitalized splenic tissues when it was expected in when less than 25% of the spleen could be preserved
  • patients who had failed NOM
  • patients with pathologic splenic rupture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of hepatobiliary surgery,Southwest Hospital

Chongqing, Chongqing Municipality, 400038, China

Location

MeSH Terms

Interventions

Radiofrequency Ablation

Intervention Hierarchy (Ancestors)

Radiofrequency TherapyTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • Kuansheng Ma, Ph.D

    Institute of hepatobiliary surgery,Southwest Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

March 20, 2019

First Posted

March 26, 2019

Study Start

March 1, 2009

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

March 26, 2019

Record last verified: 2009-03

Data Sharing

IPD Sharing
Will not share

Locations